WO1997016161A1 - Underarm compositions - Google Patents

Underarm compositions Download PDF

Info

Publication number
WO1997016161A1
WO1997016161A1 PCT/EP1996/004318 EP9604318W WO9716161A1 WO 1997016161 A1 WO1997016161 A1 WO 1997016161A1 EP 9604318 W EP9604318 W EP 9604318W WO 9716161 A1 WO9716161 A1 WO 9716161A1
Authority
WO
WIPO (PCT)
Prior art keywords
wax
composition
weight
volatile
underarm
Prior art date
Application number
PCT/EP1996/004318
Other languages
French (fr)
Inventor
Martinho Correia
Desmond Bernard Hagan
Original Assignee
Unilever Plc
Unilever N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc, Unilever N.V. filed Critical Unilever Plc
Priority to AU72851/96A priority Critical patent/AU729120B2/en
Priority to EP96934535A priority patent/EP0869770A1/en
Priority to BR9611179A priority patent/BR9611179A/en
Priority to CA002234930A priority patent/CA2234930C/en
Priority to JP9516107A priority patent/JP2000500434A/en
Publication of WO1997016161A1 publication Critical patent/WO1997016161A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8105Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
    • A61K8/8111Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/893Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by an alkoxy or aryloxy group, e.g. behenoxy dimethicone or stearoxy dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients
    • A61K2800/31Anhydrous

Definitions

  • the invention relates to novel cream underarm compositions which contain a structuring wax material. More particularly, the invention concerns antiperspirant and deodorant compositions for topical application to the human skin, containing structuring wax, a clay material and a masking oil.
  • underarm compositions for topical application to contain non-volatile silicone fluids such as polyorganosiloxanes which impart emolliency to the composition and can provide a masking effect to conceal solids present in the composition.
  • non-volatile silicone fluids such as polyorganosiloxanes which impart emolliency to the composition and can provide a masking effect to conceal solids present in the composition.
  • solids include antiperspirant actives.
  • the efficacy of the composition is not seriously affected by the presence of the non-volatile silicone.
  • An example of such compositions is to be found in EP 28853 (The Procter & Gamble Company) .
  • EP 549223 (Dow Corning) describes stick, roll on and spray underarm compositions containing certain long chain alkyl silicone waxes.
  • the waxes are alleged to provide the formulations with desirable characteristics such as improved hardness, reduced whitening, improved skin feel and compatibility with other ingredients.
  • suspension compositions which are generally preferred to the already known emulsion compositions which have been found to produce undesirable sensations on the skin such as a sticky or wet feeling.
  • the suspending agent facilitates the efficient suspension of powder materials such as antiperspirant actives in the composition to enhance efficacy and stability of the composition on storage.
  • suspending agents of the prior art whilst improving skin feel in some respects (e.g. reducing the wet sensation) impart other undesirable sensations to the skin such as grittiness and can also result in visible deposits on the skin and fabrics.
  • EP135315 (The Mennen Company) describes a clay free antiperspirant product containing a volatile silicone and a gelling agent.
  • the omission of the clay suspending agent can result in a product which is still unstable at high temperatures and over prolonged periods and which has a lowered viscosity which can be undesirable in cream formulations.
  • An object of the invention is to overcome the disadvantages of the formulations of the prior art.
  • a substantially anhydrous underarm cream composition suitable for topical application to the human skin, comprising an antiperspirant and/or deodorant agent, 0.5% to 3% by weight of a clay suspending or thickening agent, 5.0% to 25% by weight of a non-volatile masking agent, 3 to 20% by weight of a structuring wax having a melting point of at least 45°C, and 20 to 90% volatile carrier fluid, obtainable by shearing together at least the antiperspirant and/or deodorant agent, the clay, the masking agent, the carrier fluid and the wax above the melting point of said wax.
  • the underarm cream composition comprises 1% to 2% by weight of clay.
  • the clay is selected from the group comprising bentonites, smectites, saponites, reacted variants thereof and mixtures thereof.
  • the underarm composition comprises 5% to 15% by weight structuring wax and the structuring wax is selected from the group comprising alkyl methyl siloxane waxes, alkyl ester siloxane waxes, insect and animal waxes, fatty acids, fatty alcohols, fatty acid esters and fatty acid amides and mixtures thereof .
  • the alkyl methyl siloxane wax is a wax having a general formula I:
  • R is a C16-C40 alkyl group, X is 10 to 50, and Me is a CH 3 group and the average terminal alkyl chain length is at least C30.
  • R is a C25-C40 alkyl group.
  • alkyl ester siloxane wax is a wax of general formula II:
  • Me is CH 3 ;
  • R is a straight or branched chain alkyl from C 10 H 21 to C 30 H 61 .
  • R is C 19 H 39 , a is 1 and b is 3 . O 97/161 1
  • the non-volatile masking oil is selected from the group comprising non-volatile silicones and polyolefins or mixtures thereof. More preferably, the polyolefin is polydecene.
  • the volatile carrier fluid is a volatile silicone.
  • the antiperspirant agent is an inorganic and/or organic source of aluminum and zirconium or a mixture thereof.
  • the invention provides a substantially anhydrous cream antiperspirant composition
  • a substantially anhydrous cream antiperspirant composition comprising 5 to 30% by weight antiperspirant agent, 0.5% to 3% by weight of a clay suspending or thickening agent, 5% to 25% by weight of a non-volatile masking agent, 3% to 20% by weight of a structuring wax having a melting point of at least 45°C and 20 to 86.5% volatile carrier fluid, obtainable by shearing together at least the antiperspirant, the masking agent, the carrier fluid and the clay and the wax at a temperature equal to or above the melting point of said wax.
  • creams are defined in terms of cone penetration values.
  • a typical cream can be described as having a cone penetration value of between approximately 10mm and 30mm where the cone has a diameter of 16.5mm and a weight of 102.5g.
  • Suitable clays are hectorires and montmorillionites including bentonites, smectites, saponites and reacted variants thereof.
  • a preferred bentonite is Bentone 38 available from NL Industries.
  • a single clay or a blend of clays can be used.
  • antiperspirant salts include inorganic and organic salts of aluminium and zirconium and mixtures thereof. Particularly preferred are the aluminium/zirconium salts of aluminium halides, aluminium hydroxyhalides, aluminium zirconium salts and mixtures thereof. Particularly preferred antiperspirant salts include activated aluminium chlorohydrate compounds as described in EP6739 (Unilever NV et al) . Further antiperspirant actives are described in EP 28853. The contents of both these applications are incorporated herein by reference.
  • any effective deodorant composition known in the art is suitable for incorporation into the composition e.g. sodium bicarbonate, zinc ricinoleate, other inorganic salts, short chain monohydric alcohols, polyhydric alcohols or compounds such as triclosan.
  • the deodorants can be utilised alone or in conjunction with the antiperspirant active component where compatible.
  • the carrier fluid suitably comprises a volatile silicone material.
  • volatile silicone material examples include cyclic or linear polydimethylsiloxanes.
  • Preferred cyclic polydimethylsiloxanes have from 3 - 7 silicone atoms and a viscosity less than 10 mm 2 s "1 (cSt) at 25°C.
  • Preferred linear polydimethylsiloxanes have from 3 - 9 silicone atoms and a viscosity of less than 5 m ⁇ rs "1 at 25°C.
  • Preferred polydimethylsiloxanes are available from Dow Corning Corporation as Dow Corning 344 and 345.
  • the volatile silicone is present at a level of 30 to 60% by weight, more preferably 40 to 60% by weight.
  • the non-volatile masking agent is also present in the formulation and preferably comprises a hydrocarbon polymer such as poly olefins.
  • the poly olefins are suitably hydrocarbon polymers, with the preferred ones being liquid at room temperature (i.e. 21°C) . It is also highly preferred that the poly olefin in the composition has a relatively low viscosity. Preferably, the viscosity of the poly olefin hydrocarbon masking agent is less than about 40 cSt at 40°C, more preferably less than about 30 cSt at 40°C.
  • the poly olefin comprises a poly alpha olefin.
  • Preferred poly alpha olefins for use in compositions according to the invention are polydecenes, for example the Silkflo range of polydecenes, manufactured by Albermarle Corporation.
  • Other preferred poly olefins for use in compositions according to the invention include polybutene, which is commercially available under the trade name Panalene
  • preferred poly olefins for use in compositions according to the invention may have monomer chain lengths in the region of 3-15 carbon atoms.
  • Preferred poly olefin blends which are commercially available may conveniently contain a blend of various polymers, including dimers, trimers, and so on.
  • Preferred materials for use in compositions according to the invention include Silkflo 362NF, Silkflo 364NF, and Silkflo 366NF, available from Albermarle Corporation.
  • the poly olefin hydrocarbons described help to confer to the composition surprisingly good sensory properties, including a surprising lack of greasiness after application, and where the composition is an antiperspirant composition, provide an enhanced degree of masking of any whiteness that may be left by the antiperspirant salt in the composition.
  • poly olefin hydrocarbons An advantage of using the poly olefin hydrocarbons is that they have been found not to interfere with the efficacy of any antiperspirant active salt in the composition to any major degree.
  • the non-volatile masking oil which can function as an emollient can also be a non-volatile silicone.
  • the non ⁇ volatile silicone may be a polyalkyl siloxane, a polyalkaryl siloxane or a polyether siloxane copolymer.
  • Preferred polyalkysiloxanes have viscosities ranging from 10 to 100,000 mm 2 s "1 (cSt) at 25°C. Such siloxanes are available from the Dow Corning Corporation as the Dow Corning 200 series.
  • Suitable polyalkaryl siloxanes are the polymethylphenylsiloxanes having viscosities of 15 to 65mm 2 s "1 (cSt) at 25°C. These siloxanes are available as the Dow Corning 556 fluid.
  • a suitable polyether siloxane is dimethyl polyoxyalkylene ether copolymer having a approximate viscosity of 1200 to 1500 mms ⁇ 1 (cSt) at 25°C e.g. a polysiloxane ethylene glycol ether copolymer.
  • Preferred structuring waxes are the alkyl methylsiloxanes.
  • Suitable alkyl methylsiloxanes include those having the general formula (I):
  • the structuring waxes have been found to exhibit a significant masking effect on the formulations to conceal deposition of actives and suspending agents.
  • the alkylmethylsiloxane wax preferably has a melting point of greater than 45°C.
  • the alkylmethylsiloxane wax is made up of C16 to C40 alkyl groups, more preferably C25 to C35.
  • such waxes will be made up of a blend of alkyl group chain lengths with the characteristics of the wax and hence its structuring effect being determined by the blend of chain lengths utilised.
  • the waxes selected having terminal long alkyl chains are particularly effective at structuring the composition.
  • Pendant C30 and upwards species and C16 to C18 terminal alkyl waxes sometimes result in excessively soft solids which may fail to keep a stable structure following heat storage which results in an excessively thin composition. Similar difficulties are experienced when the average terminal alkyl chain length is below C30.
  • a preferred alkylmethylsiloxane wax is known as GE wax SF1642 available from the General Electric Company in which the main alkyl species are C30, C32 and C34 with minor amounts of C26 and C28.
  • the structuring wax can also be an alkyl ester siloxane wax of general formula (II) :
  • R is a straight or branched chain alkyl from C 10 H 21 to C 30 H 61
  • R is a straight chain alkyl C 19 H 39 .
  • a is suitably 1 and b is suitably 3.
  • the wax used in compositions according to the invention is an alkyl ester silicone wax.
  • the inclusion of this wax in the formulation may impart some emolliency to the composition. Accordingly, it is possible to do without, or reduce, the amount of emollient materials, such as volatile or non- volatile silicones, which are conventionally included in such compositions .
  • a particularly preferred alkyl ester silicone wax for use in compositions according to the invention is a behenic acid silicone wax, which in general structure (II) has a value for a of 1 and for b of 3 , and in addition has R as C 19 H 39 .
  • a wax is available from Rhone Poulenc under the tradename Mirasil-B 71649 wax.
  • High melting point waxes include insect and animal waxes such as beeswax and spermaceti; vegetable waxes such as carnauba, candelilla, Ouricury, Japan wax, Douglas-fir bark wax, rice-bran wax, castor wax and bayberry wax; mineral waxes such as montan wax, peat wax, ozokerite and ceresin; petroleum waxes such as paraffin wax; synthetic waxes such as Fischer-Tropsch waxes, polyethylene waxes, chemically modified hydrocarbon waxes and substituted amide waxes.
  • high melting point waxes include insect and animal waxes such as beeswax and spermaceti; vegetable waxes such as carnauba, candelilla, Ouricury, Japan wax, Douglas-fir bark wax, rice-bran wax, castor wax and bayberry wax; mineral waxes such as montan wax, peat wax, ozokerite and ceresin; petroleum waxes such as paraffin wax; synthetic wax
  • low melting point waxes examples include fatty acids, fatty alcohols, fatty acid esters and fatty acid amides having carbon chains of 3 to 30 carbon atoms.
  • Particularly preferred low melting point waxes include stearyl alcohol, cetyl alcohol, myristyl alcohol and palmitic acid.
  • the wax structurant can be a single wax or blend of the aforementioned waxes selected to provide the desired melting point and skin feel characteristics. For instance, a combination of 6% SF1642 and 5% Castorwax MP80 is particularly effective and results in a wax structurant which shears at approximately 45°C.
  • An anhydrous antiperspirant cream having the following formulation:
  • Non-Volatile Hydrocarbon Deposit Masker 10.0 (Albemarle Silkflo 364NF)
  • the cream was made by using the following four stages:
  • Stage 3 5.0% Castorwax MP80, 6.0% GE Wax SF1642 Premelt waxes at 80°C and then add to main vessel with stirring at full speed.
  • Example 1 The above cream in Example 1 was manufactured with the omission of Bentone.
  • the Bentone was replaced by 1% volatile silicone carrier fluid and manufactured in the same way.
  • 13/20 selected the Bentone-containing cream as less greasy than the non-Bentone control (significant difference at >86% confidence) .
  • the Bentone containing composition was more viscous than the non-Bentone equivalent
  • the Bentone containing composition when processed at 68°C, sheared for 10 minutes and then filled at 55 deg°C a composition having a viscosity ranging from 235,000 to 240,000 cps was obtained.
  • the identical non-Bentone composition had a viscosity of 220,000 cps.
  • the Bentone composition had a viscosity of 472,000 cps whereas the Bentone free composition had a viscosity of 360,000 cps.
  • An anhydrous antiperspirant cream having the following composition was prepared as described in Example 1:
  • a Carri-Med Controlled Stress Rheometer CSLIOO instrument was used.
  • a vane/cup measuring system was employed with a mesh interior fitted to the cup to ensure prevention of wall slip. Experiments were carried out at 25°C unless otherwise stated. Equilibrium flow experiments were conducted on fresh samples to obtain the exact flow properties of the sample. The sample was allowed to equilibrate at a fixed temperature (25°C) for one hour before measuring to ensure no temperature gradient.
  • Figure 1 shows the rheological properties of the composition of Example 2 when processed at 29°C, 45°C and 60°C. As shown in the Figure low temperatures did not result in a stable structured product. Low equilibrium viscosity figures are usually an indication that the product will show leakage of carrier fluid.
  • Example 2 when processed at 29°C resulted in an unstable composition while the samples processed at 45°C and 60°C were significantly more stable and hence less disposed towards carrier leakage.
  • Talc 5.0 organically modified smectite clay gelled in isopropyl myristate, from Steetley/NL Industries
  • Waxenol 822 (8) 1.0 Diisopropyl dilinoleate (Pripure 3786 DIPD) 7.0

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

A substantially anhydrous underarm cream composition suitable for topical application to the human skin, comprising an antiperspirant and/or deodorant agent, 0.5 % to 3 % by weight of a clay suspending or thickening agent, 5.0 % to 25 % by weight of a non-volatile masking agent, 3 to 20 % by weight of a structuring wax having a melting point of at least 45 °C, and 20 to 90 % volatile carrier fluid, obtainable by shearing together at least the antiperspirant and/or deodorant agent, the clay, the masking agent, the carrier fluid and the wax above the melting point of said wax.

Description

UNDERARM COMPOSITIONS
The invention relates to novel cream underarm compositions which contain a structuring wax material. More particularly, the invention concerns antiperspirant and deodorant compositions for topical application to the human skin, containing structuring wax, a clay material and a masking oil.
It is known for underarm compositions for topical application to contain non-volatile silicone fluids such as polyorganosiloxanes which impart emolliency to the composition and can provide a masking effect to conceal solids present in the composition. Examples of such solids include antiperspirant actives. The efficacy of the composition is not seriously affected by the presence of the non-volatile silicone. An example of such compositions is to be found in EP 28853 (The Procter & Gamble Company) .
It is also known to include certain categories of alkyl siloxane waxes in underarm compositions. EP 549223 (Dow Corning) describes stick, roll on and spray underarm compositions containing certain long chain alkyl silicone waxes. The waxes are alleged to provide the formulations with desirable characteristics such as improved hardness, reduced whitening, improved skin feel and compatibility with other ingredients.
Our co-pending British Patent Application Number 9506039.8 describes the use of alkyl ester siloxane waxes to improve the sensory properties such as skin feel of underarm compositions.
The abovementioned formulations of the prior art describe suspension compositions which are generally preferred to the already known emulsion compositions which have been found to produce undesirable sensations on the skin such as a sticky or wet feeling. The suspending agent facilitates the efficient suspension of powder materials such as antiperspirant actives in the composition to enhance efficacy and stability of the composition on storage.
However, many suspending agents of the prior art, whilst improving skin feel in some respects (e.g. reducing the wet sensation) impart other undesirable sensations to the skin such as grittiness and can also result in visible deposits on the skin and fabrics.
In an attempt to overcome this problem EP135315 (The Mennen Company) describes a clay free antiperspirant product containing a volatile silicone and a gelling agent. However, the omission of the clay suspending agent can result in a product which is still unstable at high temperatures and over prolonged periods and which has a lowered viscosity which can be undesirable in cream formulations.
An object of the invention is to overcome the disadvantages of the formulations of the prior art.
According to the invention there is provided a substantially anhydrous underarm cream composition suitable for topical application to the human skin, comprising an antiperspirant and/or deodorant agent, 0.5% to 3% by weight of a clay suspending or thickening agent, 5.0% to 25% by weight of a non-volatile masking agent, 3 to 20% by weight of a structuring wax having a melting point of at least 45°C, and 20 to 90% volatile carrier fluid, obtainable by shearing together at least the antiperspirant and/or deodorant agent, the clay, the masking agent, the carrier fluid and the wax above the melting point of said wax. Preferably, the underarm cream composition comprises 1% to 2% by weight of clay. Suitably, the clay is selected from the group comprising bentonites, smectites, saponites, reacted variants thereof and mixtures thereof.
Preferably, the underarm composition comprises 5% to 15% by weight structuring wax and the structuring wax is selected from the group comprising alkyl methyl siloxane waxes, alkyl ester siloxane waxes, insect and animal waxes, fatty acids, fatty alcohols, fatty acid esters and fatty acid amides and mixtures thereof .
Preferably, the alkyl methyl siloxane wax is a wax having a general formula I:
R- (SiMe,-0-) xSiMe,R wherein
R is a C16-C40 alkyl group, X is 10 to 50, and Me is a CH3 group and the average terminal alkyl chain length is at least C30.
Preferably R is a C25-C40 alkyl group.
Alternatively, the alkyl ester siloxane wax is a wax of general formula II:
(Me3Si)0(SiMe20)0Si (Me) (CH2) b-0-COR(SiMe3)
wherein a is an integer from 0 to 2; b is an integer from 2 to 4;
Me is CH3;
R is a straight or branched chain alkyl from C10H21 to C30H61 .
Suitably , R is C19H39 , a is 1 and b is 3 . O 97/161 1
Preferably, the non-volatile masking oil is selected from the group comprising non-volatile silicones and polyolefins or mixtures thereof. More preferably, the polyolefin is polydecene.
Suitably, the volatile carrier fluid is a volatile silicone. Advantageously, the antiperspirant agent is an inorganic and/or organic source of aluminum and zirconium or a mixture thereof.
In an alternative embodiment the invention provides a substantially anhydrous cream antiperspirant composition comprising 5 to 30% by weight antiperspirant agent, 0.5% to 3% by weight of a clay suspending or thickening agent, 5% to 25% by weight of a non-volatile masking agent, 3% to 20% by weight of a structuring wax having a melting point of at least 45°C and 20 to 86.5% volatile carrier fluid, obtainable by shearing together at least the antiperspirant, the masking agent, the carrier fluid and the clay and the wax at a temperature equal to or above the melting point of said wax.
Generally, creams are defined in terms of cone penetration values. A typical cream can be described as having a cone penetration value of between approximately 10mm and 30mm where the cone has a diameter of 16.5mm and a weight of 102.5g.
Surprisingly, it has now been found that by combining a structuring wax having specified melting point characteristics with a clay suspending agent and a non¬ volatile masking agent and subjecting the mixture to shear above the melting point an underarm composition which is stable for long periods and at high temperatures is obtained. However, the composition does not exhibit any of the undesirable characteristics such as poor skin feel and deposition previously associated with clay containing underarm compositions.
Suitable clays are hectorires and montmorillionites including bentonites, smectites, saponites and reacted variants thereof. A preferred bentonite is Bentone 38 available from NL Industries. A single clay or a blend of clays can be used.
Typically used antiperspirant salts include inorganic and organic salts of aluminium and zirconium and mixtures thereof. Particularly preferred are the aluminium/zirconium salts of aluminium halides, aluminium hydroxyhalides, aluminium zirconium salts and mixtures thereof. Particularly preferred antiperspirant salts include activated aluminium chlorohydrate compounds as described in EP6739 (Unilever NV et al) . Further antiperspirant actives are described in EP 28853. The contents of both these applications are incorporated herein by reference.
Any effective deodorant composition known in the art is suitable for incorporation into the composition e.g. sodium bicarbonate, zinc ricinoleate, other inorganic salts, short chain monohydric alcohols, polyhydric alcohols or compounds such as triclosan. The deodorants can be utilised alone or in conjunction with the antiperspirant active component where compatible.
The carrier fluid suitably comprises a volatile silicone material. Examples of such materials are cyclic or linear polydimethylsiloxanes. Preferred cyclic polydimethylsiloxanes have from 3 - 7 silicone atoms and a viscosity less than 10 mm2s"1 (cSt) at 25°C. Preferred linear polydimethylsiloxanes have from 3 - 9 silicone atoms and a viscosity of less than 5 mπrs"1 at 25°C. Preferred polydimethylsiloxanes are available from Dow Corning Corporation as Dow Corning 344 and 345. Preferably, if used in the composition, the volatile silicone is present at a level of 30 to 60% by weight, more preferably 40 to 60% by weight.
The non-volatile masking agent is also present in the formulation and preferably comprises a hydrocarbon polymer such as poly olefins.
The poly olefins are suitably hydrocarbon polymers, with the preferred ones being liquid at room temperature (i.e. 21°C) . It is also highly preferred that the poly olefin in the composition has a relatively low viscosity. Preferably, the viscosity of the poly olefin hydrocarbon masking agent is less than about 40 cSt at 40°C, more preferably less than about 30 cSt at 40°C.
Preferably, the poly olefin comprises a poly alpha olefin. Preferred poly alpha olefins for use in compositions according to the invention are polydecenes, for example the Silkflo range of polydecenes, manufactured by Albermarle Corporation. Other preferred poly olefins for use in compositions according to the invention include polybutene, which is commercially available under the trade name Panalene
L14E from Amoco, and polyisobutene, which can be obtained from Prespere under the trade name Permethyl.
As such, preferred poly olefins for use in compositions according to the invention may have monomer chain lengths in the region of 3-15 carbon atoms. Preferred poly olefin blends which are commercially available may conveniently contain a blend of various polymers, including dimers, trimers, and so on. Preferred materials for use in compositions according to the invention include Silkflo 362NF, Silkflo 364NF, and Silkflo 366NF, available from Albermarle Corporation.
When used in compositions according to the invention, the poly olefin hydrocarbons described help to confer to the composition surprisingly good sensory properties, including a surprising lack of greasiness after application, and where the composition is an antiperspirant composition, provide an enhanced degree of masking of any whiteness that may be left by the antiperspirant salt in the composition.
An advantage of using the poly olefin hydrocarbons is that they have been found not to interfere with the efficacy of any antiperspirant active salt in the composition to any major degree.
The non-volatile masking oil which can function as an emollient can also be a non-volatile silicone. The non¬ volatile silicone may be a polyalkyl siloxane, a polyalkaryl siloxane or a polyether siloxane copolymer. Preferred polyalkysiloxanes have viscosities ranging from 10 to 100,000 mm2s"1 (cSt) at 25°C. Such siloxanes are available from the Dow Corning Corporation as the Dow Corning 200 series.
Suitable polyalkaryl siloxanes are the polymethylphenylsiloxanes having viscosities of 15 to 65mm2s"1 (cSt) at 25°C. These siloxanes are available as the Dow Corning 556 fluid.
A suitable polyether siloxane is dimethyl polyoxyalkylene ether copolymer having a approximate viscosity of 1200 to 1500 mms~1 (cSt) at 25°C e.g. a polysiloxane ethylene glycol ether copolymer.
Preferred structuring waxes are the alkyl methylsiloxanes. Suitable alkyl methylsiloxanes include those having the general formula (I):
R - (SiMe2-0-)x SiMe2R where R = C16 to C40
X = 10-50 Me = CH3
The structuring waxes have been found to exhibit a significant masking effect on the formulations to conceal deposition of actives and suspending agents. The alkylmethylsiloxane wax preferably has a melting point of greater than 45°C.
Preferably, the alkylmethylsiloxane wax is made up of C16 to C40 alkyl groups, more preferably C25 to C35.
Generally, such waxes will be made up of a blend of alkyl group chain lengths with the characteristics of the wax and hence its structuring effect being determined by the blend of chain lengths utilised.
The waxes selected having terminal long alkyl chains are particularly effective at structuring the composition. Pendant C30 and upwards species and C16 to C18 terminal alkyl waxes sometimes result in excessively soft solids which may fail to keep a stable structure following heat storage which results in an excessively thin composition. Similar difficulties are experienced when the average terminal alkyl chain length is below C30.
A preferred alkylmethylsiloxane wax is known as GE wax SF1642 available from the General Electric Company in which the main alkyl species are C30, C32 and C34 with minor amounts of C26 and C28. The structuring wax can also be an alkyl ester siloxane wax of general formula (II) :
(Me3Si)0(SiMe20)aSi (Me) (CH2)b-0-COR(SiMe3)
where a is an integer from 0 to 2 b is an integer from 2 to 4 Me is CH3
R is a straight or branched chain alkyl from C10H21 to C30H61
Suitably, R is a straight chain alkyl C19H39. In addition, a is suitably 1 and b is suitably 3.
The wax used in compositions according to the invention is an alkyl ester silicone wax. The inclusion of this wax in the formulation may impart some emolliency to the composition. Accordingly, it is possible to do without, or reduce, the amount of emollient materials, such as volatile or non- volatile silicones, which are conventionally included in such compositions .
A particularly preferred alkyl ester silicone wax for use in compositions according to the invention is a behenic acid silicone wax, which in general structure (II) has a value for a of 1 and for b of 3 , and in addition has R as C19H39. Such a wax is available from Rhone Poulenc under the tradename Mirasil-B 71649 wax.
Other structurant waxy materials which may also be employed in accordance with the present invention include high and low melting point waxes, gums, resins, polymers, starches and elastomers. High melting point waxes include insect and animal waxes such as beeswax and spermaceti; vegetable waxes such as carnauba, candelilla, Ouricury, Japan wax, Douglas-fir bark wax, rice-bran wax, castor wax and bayberry wax; mineral waxes such as montan wax, peat wax, ozokerite and ceresin; petroleum waxes such as paraffin wax; synthetic waxes such as Fischer-Tropsch waxes, polyethylene waxes, chemically modified hydrocarbon waxes and substituted amide waxes. Examples of low melting point waxes include fatty acids, fatty alcohols, fatty acid esters and fatty acid amides having carbon chains of 3 to 30 carbon atoms. Particularly preferred low melting point waxes include stearyl alcohol, cetyl alcohol, myristyl alcohol and palmitic acid.
The wax structurant can be a single wax or blend of the aforementioned waxes selected to provide the desired melting point and skin feel characteristics. For instance, a combination of 6% SF1642 and 5% Castorwax MP80 is particularly effective and results in a wax structurant which shears at approximately 45°C.
EXAMPLES
Example 1
An anhydrous antiperspirant cream was produced having the following formulation:
Ingredient Function % wt
AZAG (Powder) Antiperspirant 24.0
Castorwax MP80 Structurant 5.0
GE SF1642 (1229-425) Silicone Wax & 6.0
Deposit Masker
Bentone Structurant 1.0 Volatile Silicone Carrier Fluid 45.0
Non-Volatile Hydrocarbon Deposit Masker 10.0 (Albemarle Silkflo 364NF)
Talc (Suprafino) Aid Dry Skin-Feel 8.0
Fragrance 1.0
The cream was made by using the following four stages:
Stage 1: 10.0% Silkflo 364NF, 45.0% Volatile Silicon DC345
Add Silkflo to Volatile Silicone, start stirrer to half speed and heat to 66°C.
Stage 2: 1.0% Bentone 38, 8.0% Suprafino Talc, 24.0% AZAG Powder
Draw in powders and mix for 5 minutes. After addition is complete, reheat to 66°C.
Stage 3: 5.0% Castorwax MP80, 6.0% GE Wax SF1642 Premelt waxes at 80°C and then add to main vessel with stirring at full speed.
Stage 4: 1.0% Fragrance
Add perfume and shear for 5 minutes at 68-70°C.
Comparative Example:
The above cream in Example 1 was manufactured with the omission of Bentone. The Bentone was replaced by 1% volatile silicone carrier fluid and manufactured in the same way.
Comparative Data (Sensory)
20 panellists applied O.lg of a cream to the backs of their hands, rubbed for 5 seconds and then made tactile assessments of dryness and greasiness. 14/20 selected the Bentone- containing cream as the drier (significant difference at >94% confidence) over the non-Bentone control cream.
For greasiness, 13/20 selected the Bentone-containing cream as less greasy than the non-Bentone control (significant difference at >86% confidence) .
The above results with regard to greasiness and dryness are summarised in Table I.
Comparative Data (Processing) :
In terms of processing benefit, the Bentone containing composition was more viscous than the non-Bentone equivalent For instance, the Bentone containing composition when processed at 68°C, sheared for 10 minutes and then filled at 55 deg°C a composition having a viscosity ranging from 235,000 to 240,000 cps was obtained.
The identical non-Bentone composition had a viscosity of 220,000 cps.
Moreover, when the product was processed and filled at 68°C, and mixed as above for 10 minutes, then the Bentone composition had a viscosity of 472,000 cps whereas the Bentone free composition had a viscosity of 360,000 cps.
Example 2
An anhydrous antiperspirant cream having the following composition was prepared as described in Example 1:
Ingredient %wt
AZAG (powder) 24.0
Castorwax MP80 5.0 GE SF1642 6.0
Bentone 1.0
Volatile Silicone 43.0
Silkflo 364NF 14.0
Talc 6.0 Fragrance 1.0
Rheolocrv
The rheology of the formulation of example 2 was examined to demonstrate the stability characteristics of the composition when processed at various temperatures.
A Carri-Med Controlled Stress Rheometer CSLIOO instrument was used. A vane/cup measuring system was employed with a mesh interior fitted to the cup to ensure prevention of wall slip. Experiments were carried out at 25°C unless otherwise stated. Equilibrium flow experiments were conducted on fresh samples to obtain the exact flow properties of the sample. The sample was allowed to equilibrate at a fixed temperature (25°C) for one hour before measuring to ensure no temperature gradient.
The data produced resulted in an equilibrium viscosity figure (Pa.s) which occurs under low shear stress and the point at which the sample catastrophically fails. The lower the equilibrium viscosity figure the more unstable the sample.
Results
Figure 1 shows the rheological properties of the composition of Example 2 when processed at 29°C, 45°C and 60°C. As shown in the Figure low temperatures did not result in a stable structured product. Low equilibrium viscosity figures are usually an indication that the product will show leakage of carrier fluid.
As shown in the Figure the composition of Example 2 when processed at 29°C resulted in an unstable composition while the samples processed at 45°C and 60°C were significantly more stable and hence less disposed towards carrier leakage.
The following examples describe compositions produced according to the method described for Example 1 in which a variety of waxes, clays, and emollients are used. Exampl e 3
Ingredient % wt
Aluminium Zirconium Tetrachlorohydrex Glycine Complex 25.0
Bentone 38(1> 2.0
Trihydroxy stearin 6.0
Isopropyl palmitate 11.0
Cyclomethicone DC345 60.0 Polyethylene 6.0
mSmectite clay mineral lattice containing organic cations, from Steetley/NL Industries
Example 4
Ingredient % wt
Aluminium Zirconium Octachlorohydrex Glycine Complex 22.00 Perchem 462 montmorillonite clay (from Percham) 1.25
Cyclomethicone DC245 40.10
Behenyl beeswaxate (from Koster Keunen) 6.00
Mirasil B (from Rhone Poulenc) 2.00
Polyethylene 6.65 Panalane L-14E polybutene (Amoco) 22.00
Example 5
Ingredient % wt
Aluminium Zirconium Pentachlorohydrex Glycine Complex 25.0
Bentone Gel IPM12' 3.0
Cerit SH hydrogenated castor oil (Ceralit) 4.5
Finsolv TN (C12-15 Alcohols Benzoate from Finetex) 18.0 Volatile Silicone DC244 44.5
Talc 5.0 121 organically modified smectite clay gelled in isopropyl myristate, from Steetley/NL Industries
Example 6
Ingredient % wt
Aluminium Zirconium Trichlorohydrex Glycine Complex 18.0
Bentone Gel SIL<3) 3.0 Dimethicone DC200 Fluid 350cs 25.0
Candelilla Wax 7.0
C24/C28 Alkyl Dimethicone Wax 3.5
Volatile Silicone DC344 43.5
,31 organically modified smectite clay gelled in silicone, from Steetley/NL industries
Exampl 7
Ingredient % wt
Aluminium Zirconium Tetrachlorohydrex Glycine Complex 15.0
Ozokerite Wax 8.0
Isopropyl myristate 20.0 Cyclomethicone DC345 50.0
Veegum DMI 1.0
Talc 6.0
(4) refined smectite clay from R T vanderbilt Exampl 8
Ingredient % wt
Aluminium Zirconium Pentachlorohydrex Glycine Complex 26.0
Bentone EW151 2.5
Thixcin R(6) 4.5
Cyclomethicone 52.5
Dimethicone DC200 Fluid lOOcs 5.0 C30+ Alkyl dimethicone 6.5
Polyethylene 3.0
151 powdered smectite clay from Steetley (6) hydrogenated castor oil from Rheox
Example 9
Ingredient % wt
Aluminium Chlorohydrate ultrafine powder 25.0 Hectabrite AW montmorillonite (from American Colloid) 0.8
Stearyl alcohol 7.0
Cetyl alcohol 3.0
C30 + Alkyl dimethicone 1.5 Cyclomethicone 58.9
Dry Flo 3.0
Fragrance 0.8 Example 1
Ingredient % wt
Aluminium Zirconium Trichlorohydrex Glycine Complex 25.0 Bentone 38 (Steetley/NL Industries) 1.0
Castorwax MP80'71 6.5
Waxenol 822(8) 1.0 Diisopropyl dilinoleate (Pripure 3786 DIPD) 7.0
Cylcomethicone 59.5
<7) hydrogenated castor oil
181 Eicosanol behenate from Caschem

Claims

CLAI S.
1. A substantially anhydrous underarm cream composition suitable for topical application to the human skin, comprising an antiperspirant and/or deodorant agent,
0.5% to 3% by weight of a clay suspending or thickening agent, 5.0% to 25% by weight of a non-volatile masking agent, 3 to 20% by weight of a structuring wax having a melting point of at least 45°C, and 20 to 90% volatile carrier fluid, obtainable by shearing together at least the antiperspirant and/or deodorant agent, the clay, the masking agent, the carrier fluid and the wax above the melting point of said wax.
2. An underarm composition as claimed in claim 2 characterised in that it comprises 1% to 2% by weight of clay.
3. An underarm composition as claimed in claim 1 or claim 2 characterised in that the clay is selected from the group comprising bentonites, smectites, saponites, reacted variants thereof and mixtures thereof.
4. An underarm composition as claimed in any of claims 1 to 3 characterised in that it comprises 5% to 15% by weight structuring wax.
5. An underarm composition as claimed in any of claims 1 to 4 characterised in that the structuring wax is selected from the group comprising alkylmethylsiloxane waxes, alkyl ester siloxane waxes, insect and animal waxes, fatty acids, fatty alcohols, fatty acid esters and fatty acid amides and mixtures thereof.
6. An underarm composition as claimed in claim 5 characterised in that the alkylmethylsiloxane wax is a wax having the general formula I:
R- (SiMe2-0-) xSiMe2R wherein
R is a C16-C40 alkyl group, X is 10 to 50, and Me is a CH3 group and the average terminal alkyl chain length is at least C30.
7. An underarm composition as claimed in claim 6 characterised in that R is a C25 to C40 alkyl group.
8. An underarm composition as claimed in claim 5 characterised in that the alkyl ester siloxane wax is a wax of general formula II:
(Me3Si)0(SiMe20)aSi (Me) (CH2)b-0-COR(SiMe3)
wherein a is an integer from 0 to 2; b is an integer from 2 to 4; Me is CH3; R is a straight or branched chain alkyl from C10H21 to
9. An underarm composition as claimed in claim 8 characterised in that R is C19H39, a is 1 and b is 3.
10. An underarm composition as claimed in any of claims 1 to 9 characterised in that the non-volatile masking oil is selected from the group comprising non-volatile silicones and polyolefins or mixtures thereof.
11. An underarm composition as claimed in claim 10 characterised in that the polyolefin is polydecene.
12. An underarm composition as claimed in any of claims 1 to
11 characterised in that the volatile carrier fluid is a volatile silicone.
13. An underarm composition as claimed in any of claims 1 to
12 characterised in that the antiperspirant agent is an inorganic and/or organic salt of aluminium and zirconium or a mixture thereof .
14. A substantially anhydrous cream antiperspirant composition comprising 5 to 30% by weight antiperspirant agent, 0.5% to 3% by weight of a clay suspending or thickening agent, 5% to 25% by weight of a non-volatile masking agent, 3% to 20% by weight of a structuring wax having a melting point of at least 45°C and 20 to 86.5% volatile carrier fluid, obtainable by shearing together at least the antiperspirant, the masking agent, the carrier fluid and the clay and the wax at a temperature equal to or above the melting point of said wax.
PCT/EP1996/004318 1995-10-27 1996-10-04 Underarm compositions WO1997016161A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU72851/96A AU729120B2 (en) 1995-10-27 1996-10-04 Underarm compositions
EP96934535A EP0869770A1 (en) 1995-10-27 1996-10-04 Underarm compositions
BR9611179A BR9611179A (en) 1995-10-27 1996-10-04 Cream composition
CA002234930A CA2234930C (en) 1995-10-27 1996-10-04 Underarm compositions
JP9516107A JP2000500434A (en) 1995-10-27 1996-10-04 Underarm composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9521991.1A GB9521991D0 (en) 1995-10-27 1995-10-27 Underarm compositions
GB9521991.1 1995-10-27

Publications (1)

Publication Number Publication Date
WO1997016161A1 true WO1997016161A1 (en) 1997-05-09

Family

ID=10782969

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/004318 WO1997016161A1 (en) 1995-10-27 1996-10-04 Underarm compositions

Country Status (12)

Country Link
EP (1) EP0869770A1 (en)
JP (1) JP2000500434A (en)
AR (1) AR004115A1 (en)
AU (1) AU729120B2 (en)
BR (1) BR9611179A (en)
CA (1) CA2234930C (en)
GB (1) GB9521991D0 (en)
HU (1) HUP9802997A3 (en)
PL (1) PL327241A1 (en)
RU (1) RU2189219C2 (en)
WO (1) WO1997016161A1 (en)
ZA (1) ZA968249B (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000034207A (en) * 1998-07-17 2000-02-02 L'oreal Sa Cosmetic composition containing pigment, antipersirant and solid, elastic and partially cross-linked polyorganosiloxane, and use of the composition
JP2000034211A (en) * 1998-07-17 2000-02-02 L'oreal Sa Cosmetic composition containing pigment and antipersirant, and use of the composition
WO2000030598A1 (en) * 1998-11-20 2000-06-02 The Procter & Gamble Company Low-irritation antiperspirant and deodorant compositions
EP1112053A1 (en) * 1998-09-09 2001-07-04 Clariant Life Science Molecules (Florida) Inc. Organosilicone compositions for personal care
EP1306072A3 (en) * 2001-10-24 2003-06-11 Clariant International Ltd. Homogeneous mixtures of silicone oils and organic oils
EP1393712A2 (en) * 2002-08-09 2004-03-03 Beiersdorf AG Cosmetic and dermatological antiperspirant compositions containing a clay thickening system and a polyolefine
US6849251B2 (en) 2000-04-28 2005-02-01 Henkel Kommanditgesellschaft Auf Aktien Anhydrous antiperspirant composition containing polysaccharides
US6986885B2 (en) 2000-04-04 2006-01-17 Colgate-Palmolive Company Stable and efficacious soft solid product
WO2006009993A1 (en) * 2004-06-21 2006-01-26 The Procter & Gamble Company Antiperspirant compositions comprising ozokerite
US6994845B2 (en) 2003-04-08 2006-02-07 Colgate-Palmolive Company Soft solid compositions with reduced syneresis
US9554981B2 (en) 2012-09-14 2017-01-31 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9579265B2 (en) 2014-03-13 2017-02-28 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2018590A (en) * 1978-04-14 1979-10-24 Gillette Co Antiperspirant compositions
EP0028853A2 (en) * 1979-11-07 1981-05-20 THE PROCTER &amp; GAMBLE COMPANY Antiperspirant compositions
FR2501042A1 (en) * 1981-03-09 1982-09-10 Colgate Palmolive Co ANTISUDORAL ANHYDROUS COMPOSITION
EP0549223A1 (en) * 1991-12-26 1993-06-30 Dow Corning Corporation Underarm formulations containing alkylmethylsiloxanes
GB2299024A (en) * 1995-03-24 1996-09-25 Unilever Plc Antiperspirant containing an alkyl ester siloxane

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2018590A (en) * 1978-04-14 1979-10-24 Gillette Co Antiperspirant compositions
EP0028853A2 (en) * 1979-11-07 1981-05-20 THE PROCTER &amp; GAMBLE COMPANY Antiperspirant compositions
FR2501042A1 (en) * 1981-03-09 1982-09-10 Colgate Palmolive Co ANTISUDORAL ANHYDROUS COMPOSITION
EP0549223A1 (en) * 1991-12-26 1993-06-30 Dow Corning Corporation Underarm formulations containing alkylmethylsiloxanes
GB2299024A (en) * 1995-03-24 1996-09-25 Unilever Plc Antiperspirant containing an alkyl ester siloxane

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000034207A (en) * 1998-07-17 2000-02-02 L'oreal Sa Cosmetic composition containing pigment, antipersirant and solid, elastic and partially cross-linked polyorganosiloxane, and use of the composition
JP2000034211A (en) * 1998-07-17 2000-02-02 L'oreal Sa Cosmetic composition containing pigment and antipersirant, and use of the composition
EP1112053A1 (en) * 1998-09-09 2001-07-04 Clariant Life Science Molecules (Florida) Inc. Organosilicone compositions for personal care
EP1112053A4 (en) * 1998-09-09 2002-01-02 Clariant Lsm Italia Spa Organosilicone compositions for personal care
JP2002524578A (en) * 1998-09-09 2002-08-06 クラリアント・ライフ・サイエンス・モレキユールズ(フロリダ)・インコーポレイテツド Organic silicone composition for personal care
WO2000030598A1 (en) * 1998-11-20 2000-06-02 The Procter & Gamble Company Low-irritation antiperspirant and deodorant compositions
US6986885B2 (en) 2000-04-04 2006-01-17 Colgate-Palmolive Company Stable and efficacious soft solid product
US6849251B2 (en) 2000-04-28 2005-02-01 Henkel Kommanditgesellschaft Auf Aktien Anhydrous antiperspirant composition containing polysaccharides
EP1306072A3 (en) * 2001-10-24 2003-06-11 Clariant International Ltd. Homogeneous mixtures of silicone oils and organic oils
EP1393712A2 (en) * 2002-08-09 2004-03-03 Beiersdorf AG Cosmetic and dermatological antiperspirant compositions containing a clay thickening system and a polyolefine
EP1393712A3 (en) * 2002-08-09 2004-07-07 Beiersdorf AG Cosmetic and dermatological antiperspirant compositions containing a clay thickening system and a polyolefine
US6994845B2 (en) 2003-04-08 2006-02-07 Colgate-Palmolive Company Soft solid compositions with reduced syneresis
WO2006009993A1 (en) * 2004-06-21 2006-01-26 The Procter & Gamble Company Antiperspirant compositions comprising ozokerite
US9554981B2 (en) 2012-09-14 2017-01-31 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9554982B2 (en) 2012-09-14 2017-01-31 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076490B2 (en) 2012-09-14 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076489B2 (en) 2012-09-14 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9579265B2 (en) 2014-03-13 2017-02-28 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076474B2 (en) 2014-03-13 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods

Also Published As

Publication number Publication date
PL327241A1 (en) 1998-12-07
GB9521991D0 (en) 1996-01-03
CA2234930A1 (en) 1997-05-09
HUP9802997A2 (en) 1999-03-29
RU2189219C2 (en) 2002-09-20
CA2234930C (en) 2003-02-04
JP2000500434A (en) 2000-01-18
AU7285196A (en) 1997-05-22
MX9803174A (en) 1998-09-30
EP0869770A1 (en) 1998-10-14
BR9611179A (en) 1999-03-30
AU729120B2 (en) 2001-01-25
AR004115A1 (en) 1998-09-30
ZA968249B (en) 1998-05-14
HUP9802997A3 (en) 1999-08-30

Similar Documents

Publication Publication Date Title
EP0914082B1 (en) Antiperspirant/deodorant fluid composition
US6511658B2 (en) High efficacy antiperspirant stick with concentrated elastomer
US5922308A (en) Underarm compositions
US20020001572A1 (en) Deodorant and/or antiperspirant compositions
AU729120B2 (en) Underarm compositions
MXPA01010253A (en) Antiperspirant compositions.
US6986885B2 (en) Stable and efficacious soft solid product
EP0827740B1 (en) Underarm antipersipirant or deodorant compositions comprising silica and an alkyl methicone wax
AU2001249677B9 (en) Soft solid deodorant and/or antitranspirant care product
AU2001249676A1 (en) Stable and efficacious soft solid product
US6468513B1 (en) Low residue liquid antiperspirant composition
CN103476460A (en) Soft solid antiperspirant compositions
AU728885B2 (en) Underarm compositions
US7011822B2 (en) Effective soft solid personal care product
EP1146848A1 (en) Antiperspirant composition with a high melting point wax
MXPA98003174A (en) Compositions for axi
CZ20003491A3 (en) Low residue cosmetic composition

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96199083.X

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2234930

Country of ref document: CA

Ref document number: 2234930

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1996934535

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/1998/003174

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 1997 516107

Country of ref document: JP

Kind code of ref document: A

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1996934535

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996934535

Country of ref document: EP